Mexico-based pharmaceutical sourcing, supply, distribution, manufacturing coordination, and development support for specialized medicines across Latin America.
PanAmFarma is a Mexico-based pharmaceutical company focused on the sourcing, supply, distribution, manufacturing coordination, and development support of specialized medicines for Latin America.
We support institutional, government, hospital, and authorized B2B pharmaceutical channels with access to difficult-to-source medicines, including biosimilars, oncology products, monoclonal antibodies, vaccines, plasma-related products, selected generics, and other regulated therapies.
Our work is centered on three core areas: regulated access to high-complexity medicines, cross-border pharmaceutical supply coordination, and development support for selected biosimilar, generic, and complex pharmaceutical products.
Our historical operating background dates back to 1978, when international pharmaceutical distribution across Latin America depended on handwritten documentation, telex communications, long-distance coordination, and trusted professional relationships.
One of our earliest consignments involved a cold-temperature shipment packed in insulated gel-ice containers and routed from Boston to Mexico City aboard Pan American World Airways, before onward transfer to Bogotá.
Building on its foundation in specialized medicines, PanAmFarma expanded into India-based pharmaceutical manufacturing, developed international collaborations through London-based pharmaceutical channels, acquired Mexican distribution capabilities, and completed a strategic reorganization in 2022 to strengthen its presence across Latin America.
Our product focus includes monoclonal antibodies, biologics, biosimilar insulins, oncology and chemotherapeutic medicines, vaccines, plasma and blood-derived products, selected generic medicines, and API or formulation materials under applicable controls.
Product availability, documentation, registration status, and import requirements are reviewed case by case according to the molecule, destination country, buyer qualification, manufacturer release status, and applicable regulatory pathway.
PanAmFarma works with qualified buyers, manufacturers, logistics partners, and regulatory channels to support compliant pharmaceutical transactions. Documentation, release status, import authorization, commercial terms, and quality requirements are confirmed transaction by transaction.
Professional Notice: PanAmFarma does not provide medical advice. Regulated pharmaceutical products are supplied only under applicable legal, regulatory, quality, and commercial requirements.
Our name itself honors Pan American World Airways, the carrier that made that first life-saving journey possible—and symbolizes our enduring commitment to linking continents through science, medicine, and care.
Manufacturer | Laboratory | Distributor of Specialty Pharmaceuticals
was established as a supplier of specialized molecules not available in Mexico and Latin America.
Enhancing its capabilities, it expanded its presence in Mexico and Latin America through a manufacturer and a full-service distributor of pharmaceutical products.
Specializing further in the supply of specialized molecules and finished pharmaceuticals on a small scale.
Our portfolio extends to Biosimilar, Generic and Brand Name medicines, obtained from globally recognized pharmaceutical entities and established by the World Health Organization (WHO), guaranteeing the highest standards of quality and safety.
In addition to distribution, we have expanded our operations to include the manufacturing of biosimilar and generic medications designed for the Latin American market. Our state-of-the-art manufacturing facilities are equipped to produce a wide range of pharmaceutical products, adhering to the highest standards of production and quality control while maintaining affordability.
To supply, distribute and manufacture specialized pharmaceutical products in Latin America, contributing to the health and well-being of communities through access to quality medicines.
To provide specialized pharmaceutical products that are difficult to obtain due to price or availability. To provide reliable, safe, and affordable pharmaceuticals through excellence in distribution and manufacturing practices, fostering partnerships with global and local stakeholders to meet the region’s healthcare needs.